(68), claudin-low breast cancer may originate from various stages of breast cancer development, and this is likely the best explanation for the high expression of breast cancer stem cell markers and EMT-related markers in claudin-low breast cancer as well as its overlap in gene and immune expression with luminal A/B, HER2 overexpression, and triple-negative breast cancer. Here, ERBB2 is linked to breast carcinoma.